Loading...

China Renaissance to increase investment in healthcare

Image

 Insights

23-Nov-17 China Renaissance, a Beijing investment bank and VC investor, plans to expand its operation with an additional USD7 billion to build up its healthcare/biotechnology investments including Huaxing Healthcare, and other sectors. [image: China Renaissance].

Read More

Cardinal Health sells China operations for USD557 mn

Image

 Insights

21-Nov-17 Shanghai Pharmaceuticals has agreed to pay USD557 million for Cardinal Health’s China drug distribution business, growing its nationwide presence and making it a distributor to 322 cities and 11,000 medical institutions. [image: Healthcare Packaging]

Read More
Share